OM:DVYSRBiotechs
Devyser Diagnostics Q4 Profit Of 13.6m SEK Tests Longstanding Loss Narrative
Devyser Diagnostics (OM:DVYSR) has wrapped up FY 2025 with fourth quarter revenue of 72 million SEK and EPS of 0.82 SEK, putting a clean set of numbers in front of investors off a share price of 102.6 SEK. Over recent periods the company has seen revenue move from 48.7 million SEK in Q3 2024 to 64.2 million SEK in Q4 2024 and then to 72 million SEK in Q4 2025. Quarterly EPS has swung from a loss of 1.41 SEK in Q3 2024 and 0.19 SEK in Q4 2024 to a profit of 0.82 SEK in Q4 2025, setting up a...